Dobutamine contraindications: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Dobutamine}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) INJECTION, ..." |
Ahmed Zaghw (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Contraindications== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb842dc2-fb15-48f9-e4b1-ea4280db0199 | publisher = | date = | accessdate = }}</ref> | Dobutamine hydrochloride is contraindicated in patients with [[idiopathic hypertrophic subaortic stenosis]] and in patients who have shown previous manifestations of [[hypersensitivity]] to dobutamine injection.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb842dc2-fb15-48f9-e4b1-ea4280db0199 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== |
Revision as of 22:51, 10 February 2014
Dobutamine |
---|
DOBUTamine® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
How Supplied/Storage and Handling |
Labels and Packages |
Clinical Trials on Dobutamine |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Contraindications
Dobutamine hydrochloride is contraindicated in patients with idiopathic hypertrophic subaortic stenosis and in patients who have shown previous manifestations of hypersensitivity to dobutamine injection.[1]
References
Adapted from the FDA Package Insert.